Reuters logo
BRIEF-Sumitomo Dainippon Pharma plans merger between units
December 21, 2016 / 8:02 AM / a year ago

BRIEF-Sumitomo Dainippon Pharma plans merger between units

Dec 21 (Reuters) - Sumitomo Dainippon Pharma Co Ltd :

* Says co’s wholly owned unit Boston Biomedical, Inc will merge with co’s another US-based unit Boston Biomedical Pharma, Inc, on April 1, 2017

* Says Boston Biomedical Pharma, Inc will be dissolved after the transaction

Source text in Japanese: goo.gl/3qAlQd

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below